| Financial Year |
March 31 2023 |
| Monetary Funds |
1,948,595,711.94 |
| Held-for-trading Financial Assets |
255,757,608.95 |
| Notes Receivable |
-- |
| Accounts Receivable |
740,594,271.63 |
| Advances to Suppliers |
151,479,659.37 |
| Other Receivables |
50,292,096.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
931,538,922.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
81,695,276.04 |
| Total Current Assets |
4,174,716,642.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
72,238,442.30 |
| Investment Properties |
-- |
| Fixed Assetes |
2,122,346,743.08 |
| Under-construction Projects |
432,847,892.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
559,533,979.66 |
| R&D expenses |
-- |
| Goodwill |
577,208,353.10 |
| Long-Term Deferred and Prepaid Expenses |
3,236,201.89 |
| Deferred Income Tax Assets |
49,728,126.63 |
| Other Non-Current Assets |
3,633,427.00 |
| Sub-Total of Non-Current Assets |
3,944,297,594.39 |
| Total Assets |
8,119,014,236.49 |
| Short-Term Loans |
360,110,380.49 |
| Trading Financial liabilities |
2,371,600.00 |
| Notes Payable |
22,510,075.44 |
| Accounts Payable |
563,926,750.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
122,932,687.66 |
| Taxes Payable |
28,055,163.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
166,436,118.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,356,962.28 |
| Other Current Liabilities |
9,142,156.88 |
| Sub-Total of Current Liabilities |
1,319,631,813.37 |
| Long-term Loans |
638,583,861.10 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
20,364,058.98 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
868,065,725.31 |
| Total Liabilities |
2,187,697,538.68 |
| Paid-In Capital(Or Share Stock) |
266,451,202.00 |
| Capital Surplus |
1,791,940,282.87 |
| Surplus Reserve |
197,423,724.44 |
| LESS:Treasury Stock |
36,563,983.09 |
| Undistributed Profits |
3,502,689,748.71 |
| Minority Stockholder's Interest |
215,013,039.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,716,303,658.29 |
| Owner's Equity（Stockholder's Equity） |
5,931,316,697.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,119,014,236.49 |
